This Virtual Special Issue will highlight innovative work by Early Career Scientists working on all aspects of bioconjugate chemistry. Submit your manuscripts throughout 2024.
In recent times, a spotlight has been thrown on the field of bioconjugate chemistry, following the presentation of the 2022 Nobel Prize in Chemistry to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless "for the development of click chemistry and bioorthogonal chemistry."
Bioconjugate Chemistry now wishes to turn that spotlight and shine it onto the innovative work being done in this field by early career scientists.
We invite Articles, Reviews and Viewpoints on all topics relating to bioconjugate chemistry. There are no strict guidelines for what constitutes ‘early career’—anyone who feels that phrase defines their current position is welcome to submit to this upcoming Virtual Special Issue.
Take a look at what is already included in our recent Virtual Issue on Early Career Innovators in Bioconjugate Chemistry:
Learn More
Virtual Issue: Early Career Innovators in Bioconjugate Chemistry
This Virtual Issue showcases recent innovative work by Early Career Scientists working on all aspects of bioconjugate chemistry.
Organizing Editors
Theresa Reineke, Editor-in-Chief, Bioconjugate Chemistry
University of Minnesota, United States
Peng Zou, Topic Editor, Bioconjugate Chemistry
Peking University, China
Submission Instructions
- Log in to the ACS Paragon Plus submission site and choose Bioconjugate Chemistry.
- Select your manuscript type, and, under "Special Issue Selection," choose "Early Career Innovators in Bioconjugate Chemistry."
Please see our Author Guidelines for more information on submission requirements. We welcome pre-submission inquiries, which can be sent to eic@bioconj.acs.org.
The deadline for submissions is December 31, 2024.
